Strangers in a strange land: 8 unlikely companies making plays in pharma
PharmaVoice
MAY 22, 2023
How these consumer and service companies are tapping into major trends in the biopharma industry.
May, 2023
265 
Reports patients trying to access Pharmacy First early
The Pharmacist
MAY 11, 2023
Community pharmacies have had to turn patients away who thought that new pharmacy services announced this week were already available, leaders in the sector have told. On Tuesday, NHS England announced that a nationally funded Pharmacy First service will be launched in England before the end of 2023, subject to consultation. National newspaper headlines heralded […] The post Reports patients trying to access Pharmacy First early appeared first on The Pharmacist.
Join 33,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights
Drug Patent Watch
MAY 22, 2023
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on… The post DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights appeared first on DrugPatentWatch - Make Better Decisions.
‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients
STAT
MAY 15, 2023
When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial and complicated process known as prior authorization, their emotions cycled rapidly between fear, shock, and outrage. The change, which the health insurer will implement on June 1, means that any United member seeking surveillance and diagnostic colonoscopies to detect cancer will first need approval from United — or else have to pay out of pocket.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Trick of Trade: Dual Foley catheter to control massive epistaxis
ALiEM - Pharm Pearls
MAY 29, 2023
Massive epistaxis is considered a medical emergency that requires immediate attention. Symptoms of massive epistaxis include sudden and heavy bleeding from the nose, difficulty breathing, dizziness, and a rapid heartbeat. If left untreated, it can lead to significant blood loss, shock, airway obstruction, and even death. We report a case of a 50-year-old man with end stage renal disease with massive nasal bleeding from the left nostril, shortness of breath, and confusion.
FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults
BioPharma Dive
MAY 3, 2023
The decision represents the first fruits of a scientific breakthrough a decade ago that gave drugmakers, among them GSK, Pfizer and Moderna, a blueprint for an effective shot against the virus.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
BioNTech’s RNA vaccine sparks potential in pancreatic cancer
Pharmaceutical Technology
MAY 11, 2023
Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later. In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atez
'Utterly devastating’: Cost-of-living crisis hits OTC medicines access
The Pharmacist
MAY 2, 2023
In Shilpa Shah’s area of North-East London, people ‘can't afford to be ill’. With many people accessing free prescriptions, community pharmacists in the area tend to give advice and recommend home remedies for self-limiting minor ailments, instead of over-the-counter treatments that patients would have to pay for. For a sore throat, patients might be told […] The post 'Utterly devastating’: Cost-of-living crisis hits OTC medicines access appeared first on The Pharmacist.
STAT+: Addiction treatment center founder indicted in sprawling fraud scheme
STAT
MAY 24, 2023
Over the last few years, Daniel Cleggett Jr. appeared to be living a charmed life. The founder of a small Boston-area addiction treatment empire knew he was under scrutiny; the Globe and STAT News published investigations in 2017 and 2019 into his questionable business dealings, and the Massachusetts attorney general’s office announced shortly after that it was examining alleged scams involving addiction treatment.
New PhRMA Ad Campaign Sheds Light on PBM Abuses
PhRMA
MAY 1, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health care costs and denying coverage of lifesaving medicines.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
J&J antibody drug combination shows promise in multiple myeloma
BioPharma Dive
MAY 25, 2023
A pair of dual-acting antibodies displayed early potential to become a new type of drug regimen for the blood cancer, but led to a high rate of side effects as well.
Taking your biotech global? Here’s how you can navigate cultural norms
PharmaVoice
MAY 2, 2023
What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.
US FDA approves Bausch + Lomb and Novaliq’s DED treatment Miebo
Pharmaceutical Technology
MAY 19, 2023
The US Food and Drug Administration (FDA) has granted approval to Bausch + Lomb and Novaliq’s Miebo (perfluorohexyloctane ophthalmic solution) to treat the signs and symptoms of dry eye disease (DED). Formerly known as NOV03, Miebo is a first-in-class eye drop designed for preventing the evaporation of excessive tears and restoring tear balance in evaporative DED patients.
‘The devil’s in the detail’: What will England’s national Pharmacy First service mean locally?
The Pharmacist
MAY 23, 2023
NHS England has recently announced a £645m investment in community pharmacy, some of which will be allocated to a new national Pharmacy First service for England – allowing pharmacists across England to treat seven common conditions – sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women – under […] The post ‘The devil’s in the detail’: What will England’s national Pharmacy First service mean locally?
What explains rare heart condition among young men after Covid vaccines? A new study offers clues
STAT
MAY 5, 2023
A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. Early hypotheses as to what was driving the heart inflammation, called myocarditis , included an allergic response to the vaccine, vaccine-induced antibodies, or an autoimmune response in which the immune system attacks the body’s own healthy tissue by mistake.
Americans want state policymakers to lower out-of-pocket costs
PhRMA
MAY 1, 2023
Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter.
Teva puts rival to Prometheus, Pfizer drugs at center of turnaround plans
BioPharma Dive
MAY 18, 2023
At an investor day, executives highlighted an experimental inflammatory disease drug targeting the protein TL1A as important to their long-term growth prospects.
Emalex aims at a first-in-class breakthrough for Tourette syndrome
PharmaVoice
MAY 1, 2023
With its phase 3 candidate, the biotech believes it can move the field beyond antipsychotics to a more effective approach.
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
Pharmaceutical Technology
MAY 30, 2023
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion is intended for the prevention of Covid-19 resulting from SARS-CoV-2 infection in individuals aged 18 years and above. The authorisation allows the distribution of the vaccine in Scotland, Wales and England.
Pharmacy Students can be Mothers: How can Pharmacy School better support them
Pulses
MAY 18, 2023
By: Tayana Cuffee, Pharm D Candidate and Krista Donohoe,Pharm.D., BCPS, BCGP Some pharmacy students have responsibilities caring for others, what can pharmacy schools learn from their experiences? Pharmacy school is a very rigorous program that requires a lot of time and effort both in and outside of the classroom. Pharmacy students regularly experience stressors such as high work demands, numerous assessments, Advanced Practice Pharmacy Experiences (APPEs), and finding the right career path. 1
STAT+: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys
STAT
MAY 19, 2023
A defanged form of CRISPR, which doesn’t slice or nick DNA, but rather alters the epigenome — the layers of chemical coding that sit on top of DNA and control the activity of genes — has aced its first substantive test. When researchers used CRISPR “ epigenome editing ” to dial down a cholesterol-associated gene in monkeys, the animals’ blood levels of heart-disease-causing LDL, or “bad” cholesterol, plummeted by more than 50%, Jennifer Kwo
NPR and DrugPatentWatch – Can drug injector pens be swapped?
Drug Patent Watch
MAY 16, 2023
On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which could then be swapped to fix drug shortages. Referring to… The post NPR and DrugPatentWatch – Can drug injector pens be swapped? appeared first on DrugPatentWatch - Make Better Decisions.
J&J, building on CAR-T success, strikes another cell therapy deal
BioPharma Dive
MAY 2, 2023
Fresh off its success with the multiple myeloma treatment Carvykti, J&J is paying Cellular Biomedicine Group $245 million upfront for rights to two experimental cell therapies for blood cancer.
Amid surging Duchenne market, Capricor touts potential ‘backbone’ therapy of the space
PharmaVoice
MAY 22, 2023
The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients.
European biotechs choosing Switzerland as base, research shows
European Pharmaceutical Review
MAY 23, 2023
New research by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20 percent of European biotech companies are now headquartered in Switzerland. Sixty three out of a total of 265 companies settling in Switzerland were biotechs. This makes it the second most important sector after ICT, the research found. 2022 statistics by the Swiss federal government confirm that the trend to base here is continuing.
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
Pharmaceutical Technology
MAY 31, 2023
XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will receive $250m in upfront and milestone payments. The two companies will use XtalPi’s integrated AI capabilities and robotics platform for the de novo [without consideration of previous instances] design and delivery of drug candidates for an undisclosed target.
Opinion: Cancer patients shouldn’t be responsible for out-of-pocket costs
STAT
MAY 23, 2023
In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure multiple CT and MRI studies and intensive medical care, including surgery, radiation, chemotherapy, or immunotherapy. Fortunately, advances in treatment and novel therapies have steadily improved survival following a cancer diagnosis. Cancer death rates have declined by 27% over the past 20 years.
2022 Prescription Trends
PharmExec
MAY 22, 2023
The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
FDA panel narrowly backs approval of Sarepta’s Duchenne gene therapy
BioPharma Dive
MAY 12, 2023
Advisers voted 8-6 in favor of an accelerated approval despite uncertainty around the treatment’s benefit. The agency is set to make a final decision by May 29.
The ‘superpowers’ pharma leaders should cultivate
PharmaVoice
MAY 26, 2023
Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.
Labour promises more joined-up primary care teams
The Pharmacist
MAY 24, 2023
The Labour party has pledged to improve care for patients with multiple medications and conditions by bringing primary care teams together, including by co-locating services in one site where possible. In its ‘Mission for Public Services’, the opposition party said that it aimed to give patients one point of contact for appointments with a range […] The post Labour promises more joined-up primary care teams appeared first on The Pharmacist.
The emergence of tranq amidst the fentanyl crisis
Pharmaceutical Technology
MAY 9, 2023
In February, the FDA issued an alert restricting the import of the veterinary sedative xylazine or tranq and the ingredients used to make the drug. This followed in the wake of a Drug Enforcement Agency (DEA) Joint Intelligence Report in October 2022, which stated that xylazine is widely available from Chinese suppliers on the internet. According to a June 2022 study, xylazine has been detected in the illicit drug supply in 36 US States, and the DEA has reported that approximately 30% of the f
After decades of neglecting women athletes, sport and exercise medicine is finally catching up
STAT
MAY 19, 2023
When cyclist Alison Tetrick joined the sport’s professional ranks, she received the perks that come with the job — new bikes and clothing included. But she could never get comfortable on the bike saddles. After several years, Tetrick suffered so much damage to her genital area that she eventually resorted to surgery to trim excess skin from her labia.
Should Pharmacy School Admissions Hold Off on the PCAT Retirement Party?
Pulses
MAY 9, 2023
By: Esther L. Albuquerque, Pharm D Candidate and W. Renee’ Acosta, R.Ph., M.S. The Pharmacy College Admissions Test (PCAT) has been a mainstay of the pharmacy school admissions process since 1974. The exam was designed to measure a prospective student’s academic preparedness for the rigors of the professional pharmacy curriculum. With the COVID-19 pandemic in 2020 being a barrier to pharmacy school application numbers, the PCAT was one of the first requirements that moved to optional status.
Cancer vaccine from BioNTech, Roche shows potential in small study
BioPharma Dive
MAY 10, 2023
The companies’ personalized shot generated tumor-specific T cells that researchers hope could help prevent pancreatic cancer from returning after surgery.
Let's personalize your content